Privia Health Group’s (PRVA) “Market Outperform” Rating Reaffirmed at JMP Securities

Privia Health Group (NASDAQ:PRVAGet Free Report)‘s stock had its “market outperform” rating reissued by research analysts at JMP Securities in a research note issued to investors on Friday,Benzinga reports. They presently have a $26.00 price target on the stock. JMP Securities’ price objective indicates a potential upside of 3.48% from the company’s previous close.

A number of other brokerages also recently issued reports on PRVA. JPMorgan Chase & Co. raised their price target on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Friday, November 29th. Truist Financial raised their target price on Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a report on Friday, November 8th. Needham & Company LLC initiated coverage on shares of Privia Health Group in a research note on Friday, January 10th. They set a “buy” rating and a $25.00 price target on the stock. Macquarie began coverage on shares of Privia Health Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $25.00 price objective for the company. Finally, Barclays boosted their price objective on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a report on Friday, November 8th. Two analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, Privia Health Group presently has an average rating of “Buy” and a consensus price target of $24.94.

Read Our Latest Stock Analysis on Privia Health Group

Privia Health Group Stock Performance

Privia Health Group stock traded up $0.26 during mid-day trading on Friday, reaching $25.13. 375,878 shares of the company were exchanged, compared to its average volume of 569,920. The firm’s 50-day simple moving average is $21.54 and its two-hundred day simple moving average is $20.20. Privia Health Group has a twelve month low of $15.92 and a twelve month high of $25.49. The firm has a market cap of $3.02 billion, a PE ratio of 251.23, a price-to-earnings-growth ratio of 3.07 and a beta of 0.87.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. FMR LLC grew its position in shares of Privia Health Group by 1.5% in the third quarter. FMR LLC now owns 18,169,043 shares of the company’s stock valued at $330,858,000 after purchasing an additional 271,645 shares during the period. Riverbridge Partners LLC increased its stake in shares of Privia Health Group by 19.7% during the 4th quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company’s stock valued at $113,868,000 after acquiring an additional 958,418 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Privia Health Group by 1.0% during the 3rd quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company’s stock worth $43,986,000 after acquiring an additional 23,178 shares during the period. Loomis Sayles & Co. L P boosted its position in shares of Privia Health Group by 55.0% in the fourth quarter. Loomis Sayles & Co. L P now owns 1,418,234 shares of the company’s stock worth $27,727,000 after acquiring an additional 503,002 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in Privia Health Group by 10.9% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,416,235 shares of the company’s stock valued at $27,687,000 after purchasing an additional 138,747 shares during the period. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Privia Health Group Company Profile

(Get Free Report)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Featured Articles

Analyst Recommendations for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.